Haemophilus Influenzae Type b Diseases Completed Phase 3 Trials for Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen (DB10990)

Also known as: Haemophilus Influenzae Type b Disease

IndicationStatusPhase
DBCOND0035438 (Haemophilus Influenzae Type b Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01309646Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib VaccinePrevention
NCT00412854Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.Prevention
NCT00696423Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in ChildrenPrevention
NCT00473668Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/HibPrevention
NCT00879827Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy InfantsPrevention
NCT00332566Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/HibPrevention